We also investigated the possible relevance of the presence of CALMs in relation to key prognostic factors of disease outcome, such as the likelihood of neurofibroma development, including plexiform neurofibromas, and other NF1-related complications. The gene discussed is NF1; the disease is plexiform neurofibroma.